FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383901264> ?p ?o ?g. }

• W4383901264 endingPage "42" @default.
• W4383901264 startingPage "36" @default.
• W4383901264 abstract "Objectives Our objectives were to determine the incidence, timing, and risk factors for venous thromboembolisms (VTEs) in patients with advanced stage epithelial ovarian cancer (EOC) who received neoadjuvant chemotherapy (NACT). We explored the utilization of direct-acting oral anticoagulants (DOACs) for VTE treatment. Methods This retrospective cohort study included patients with advanced stage EOC receiving NACT followed by interval cytoreductive surgery (ICS) at a single institution. Risk factors were compared between patients with versus without VTE between EOC diagnosis and 180 days after ICS. Bleeding complications were compared between patient who received a DOAC versus non-DOAC. Results VTE cases occurred amongst 33 of the 154 (21.4%) patients with 4 (2.6%) concurrent with EOC diagnosis, 9 (5.8%) between EOC diagnosis and NACT start, 13 (8.4%) between NACT start and ICS, and 7 (4.5%) within 180 days after ICS. There were no statistically significant differences in risk factors assessed (age, body mass index, functional status, histology, Khorana score, and smoking history) between patients with versus without VTE. Eleven patients (33.3%) received a DOAC for VTE treatment. There were no significant differences in number of intraoperative blood transfusions (p = 0.38), blood loss (p = 0.95), or bleeding complications (p = 0.53) between patients treated with a DOAC versus a non-DOAC. Conclusion There is a high incidence of VTE events (21.4%) in patients with advanced stage EOC undergoing NACT. Two-thirds of the VTEs may have been prevented with thromboprophylaxis as they occurred between EOC diagnosis and ICS. These data support consideration of thromboprophylaxis in all patients with advanced stage EOC undergoing NACT." @default.
• W4383901264 created "2023-07-12" @default.
• W4383901264 creator A5000164383 @default.
• W4383901264 creator A5000319988 @default.
• W4383901264 creator A5007373031 @default.
• W4383901264 creator A5016505594 @default.
• W4383901264 creator A5031945893 @default.
• W4383901264 creator A5037825413 @default.
• W4383901264 creator A5041270796 @default.
• W4383901264 creator A5050586204 @default.
• W4383901264 creator A5077315571 @default.
• W4383901264 creator A5088406750 @default.
• W4383901264 date "2023-09-01" @default.
• W4383901264 modified "2023-10-16" @default.
• W4383901264 title "Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?" @default.
• W4383901264 cites W1535929376 @default.
• W4383901264 cites W1589295587 @default.
• W4383901264 cites W1996600303 @default.
• W4383901264 cites W2003788364 @default.
• W4383901264 cites W2021442776 @default.
• W4383901264 cites W2031799746 @default.
• W4383901264 cites W2041113507 @default.
• W4383901264 cites W2042067442 @default.
• W4383901264 cites W2046089824 @default.
• W4383901264 cites W2057974138 @default.
• W4383901264 cites W2060679088 @default.
• W4383901264 cites W2101798197 @default.
• W4383901264 cites W2108423836 @default.
• W4383901264 cites W2110466835 @default.
• W4383901264 cites W2111885463 @default.
• W4383901264 cites W2117172636 @default.
• W4383901264 cites W2142092434 @default.
• W4383901264 cites W2157045478 @default.
• W4383901264 cites W2313284959 @default.
• W4383901264 cites W2579916850 @default.
• W4383901264 cites W2587122634 @default.
• W4383901264 cites W2613530077 @default.
• W4383901264 cites W2738396485 @default.
• W4383901264 cites W2754338011 @default.
• W4383901264 cites W2758757869 @default.
• W4383901264 cites W2766870001 @default.
• W4383901264 cites W2775434460 @default.
• W4383901264 cites W2799885026 @default.
• W4383901264 cites W2802130786 @default.
• W4383901264 cites W2806561309 @default.
• W4383901264 cites W2902078827 @default.
• W4383901264 cites W2917722773 @default.
• W4383901264 cites W2930432296 @default.
• W4383901264 cites W2966354200 @default.
• W4383901264 cites W2981274404 @default.
• W4383901264 cites W3006401796 @default.
• W4383901264 cites W3013809005 @default.
• W4383901264 cites W3037986900 @default.
• W4383901264 cites W3100796456 @default.
• W4383901264 cites W3116833002 @default.
• W4383901264 cites W3165875923 @default.
• W4383901264 cites W3183579715 @default.
• W4383901264 cites W3197026129 @default.
• W4383901264 cites W4212905021 @default.
• W4383901264 cites W4317931883 @default.
• W4383901264 doi "https://doi.org/10.1016/j.ygyno.2023.06.577" @default.
• W4383901264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37442024" @default.
• W4383901264 hasPublicationYear "2023" @default.
• W4383901264 type Work @default.
• W4383901264 citedByCount "3" @default.
• W4383901264 countsByYear W43839012642023 @default.
• W4383901264 crossrefType "journal-article" @default.
• W4383901264 hasAuthorship W4383901264A5000164383 @default.
• W4383901264 hasAuthorship W4383901264A5000319988 @default.
• W4383901264 hasAuthorship W4383901264A5007373031 @default.
• W4383901264 hasAuthorship W4383901264A5016505594 @default.
• W4383901264 hasAuthorship W4383901264A5031945893 @default.
• W4383901264 hasAuthorship W4383901264A5037825413 @default.
• W4383901264 hasAuthorship W4383901264A5041270796 @default.
• W4383901264 hasAuthorship W4383901264A5050586204 @default.
• W4383901264 hasAuthorship W4383901264A5077315571 @default.
• W4383901264 hasAuthorship W4383901264A5088406750 @default.
• W4383901264 hasConcept C120665830 @default.
• W4383901264 hasConcept C121332964 @default.
• W4383901264 hasConcept C121608353 @default.
• W4383901264 hasConcept C126322002 @default.
• W4383901264 hasConcept C141071460 @default.
• W4383901264 hasConcept C143998085 @default.
• W4383901264 hasConcept C146357865 @default.
• W4383901264 hasConcept C151730666 @default.
• W4383901264 hasConcept C167135981 @default.
• W4383901264 hasConcept C2776694085 @default.
• W4383901264 hasConcept C2780221984 @default.
• W4383901264 hasConcept C2780427987 @default.
• W4383901264 hasConcept C61511704 @default.
• W4383901264 hasConcept C71924100 @default.
• W4383901264 hasConcept C72563966 @default.
• W4383901264 hasConcept C86803240 @default.
• W4383901264 hasConceptScore W4383901264C120665830 @default.
• W4383901264 hasConceptScore W4383901264C121332964 @default.
• W4383901264 hasConceptScore W4383901264C121608353 @default.
• W4383901264 hasConceptScore W4383901264C126322002 @default.
• W4383901264 hasConceptScore W4383901264C141071460 @default.

• next